Found 5 matching trials
Study of the Safety of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease Currently Receiving Memantine
PHASE2The purpose of this study is to evaluate the safety of 2 fixed doses of EVP...
Location
Multiple Locations
Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
PHASE3The purpose of this study is to evaluate the safety and efficacy of 2 fixed...
Location
Multiple Locations
Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia
PHASE1This study in patients with schizophrenia is designed to provide preliminar...
Location
Clinical Research Institute
Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025
PHASE3This is a 26-week, randomized extension of the Phase 3 double-blind placebo...
Location
Multiple Locations
Study of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's Disease
PHASE3The purpose of this study is to evaluate the safety and efficacy of 2 fixed...
Location
Multiple Locations